OTTAWA, Oct. 23, 2017 -- Mitel® (Nasdaq:MITL) (TSX:MNW), a global leader in business communications, today announced that it will release its third quarter 2017 financial results for the period ended September 30, 2017 before the market opens on Thursday, November 2, 2017.
The company will host an investor conference call and live webcast at 8:30 a.m. ET (5:30 a.m. PT) on the same day. To access the conference call, dial 888-734-0328. Callers outside the US and Canada should dial 678-894-3054. The conference ID is 5897069. An audio replay will be accessible on Mitel's investor relations website at www.mitel.com on Thursday, November 2, 2017 after 12:00 p.m. ET.
About Mitel
A global market leader in business communications powering more than two billion business connections, Mitel (Nasdaq:MITL) (TSX:MNW) helps businesses and service providers connect, collaborate and provide innovative services to their customers. Our innovation and communications experts serve more than 70 million business users in more than 100 countries. For more information, go to www.mitel.com and follow us on Twitter @Mitel.
Mitel is the registered trademark of Mitel Networks Corporation.
All other trademarks are the property of their respective owners.
MITL-F
Contact Information
| Media Camille Beasley 469-212-0433 [email protected] | |
| Investor Michael McCarthy 469-574-8134, [email protected] |


Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 



